We wish to inform you regarding the order passed by the Hon''ble NCLT, Hyderabad Bench, approving the Scheme of Amalgamation
M&A
▲ Positive Development
LOW RISK
📅 Filed on BSE: 19 Jun 2026, 05:51 PM IST · BSE ID: b9035bdc-8b89-4306-8f65-849de08c301d
View Original BSE Filing (PDF)
💡
In Simple Terms
A court has approved the merger of Quality Care India into Aster DM Healthcare, pending final legal steps.
🤖 AI Summary
- Hon'ble NCLT, Hyderabad Bench, sanctioned the Scheme of Amalgamation on June 19, 2026.
- Scheme involves Quality Care India Limited (Transferor Company) and Aster DM Healthcare Limited (Transferee Company).
- Approval granted under Section 230 to 232 and other provisions of the Companies Act, 2013.
- Scheme effective upon filing certified NCLT order with Registrar of Companies and fulfilling conditions.
- Quality Care India Limited will dissolve without winding up after the Scheme becomes effective.
🏢 How This Affects the Company
The amalgamation integrates Quality Care India Limited's operations and assets into Aster DM Healthcare Limited, potentially expanding its healthcare service delivery and market reach.
The merger will consolidate the financial statements of Quality Care India Limited with Aster DM Healthcare Limited, affecting combined assets, liabilities, and future earnings.
Integration of Quality Care India Limited's operational framework, including facilities and workforce, into Aster DM Healthcare Limited's existing structure will follow.
Post-merger integration risks are present, typical for such corporate actions, though regulatory approval completion reduces uncertainty regarding the scheme's execution.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this intimation.
👤
Who Is Affected
Shareholders of Aster DM Healthcare Limited will see their company integrate Quality Care India Limited, potentially altering the combined entity's operational and financial profile post-effectiveness.
🔍
Management Signal
The successful acquisition of NCLT approval indicates management's commitment to strategic consolidation and corporate restructuring objectives.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Intimation of the Effective Date of the Scheme from the company.
Filing of the certified NCLT order with the Registrar of Companies.
Future financial disclosures reflecting the consolidated entity's performance.
LOW RISK
NCLT approval significantly de-risks the merger process, moving towards completion.
💡 Investor Takeaway
The Hon’ble NCLT, Hyderabad Bench, sanctioned the Scheme of Amalgamation between Quality Care India Limited and Aster DM Healthcare Limited on June 19, 2026. This approval removes a key regulatory step for the corporate restructuring process.
⚖️ Strengths & Concerns
✅ Positives
- NCLT approval for the Scheme of Amalgamation provides legal and regulatory clearance for the merger process.
- Consolidation of Quality Care India Limited into Aster DM Healthcare Limited streamlines corporate structure and governance.
⚠️ Concerns
- Effectiveness of the scheme is pending receipt and filing of the certified NCLT order with the Registrar of Companies.
- No specific financial or operational details of Quality Care India Limited are provided in the filing for assessment.
📅 Company Track Record
A recent filing on June 18, 2026, indicated Aster DM Healthcare acquired 4,50,89,995 equity shares for Rs. 45,08,99,950/- in its Sarjapur subsidiary, demonstrating ongoing internal corporate activities.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the recent development regarding Aster DM Healthcare's amalgamation?
The Hon’ble National Company Law Tribunal (NCLT), Hyderabad Bench, sanctioned the Scheme of Amalgamation between Quality Care India Limited and Aster DM Healthcare Limited on June 19, 2026.
Which companies are involved in the NCLT-approved amalgamation scheme?
The scheme involves Quality Care India Limited as the Transferor Company and Aster DM Healthcare Limited as the Transferee Company.
When will the amalgamation scheme for Aster DM Healthcare become effective?
The Scheme will become effective upon filing the certified copy of the NCLT order with the Registrar of Companies by the respective companies and satisfaction of other conditionalities mentioned in the Scheme.
What will happen to Quality Care India Limited after the scheme becomes effective?
Upon the Scheme becoming effective, Quality Care India Limited shall stand dissolved without winding up.
Questions based on this BSE filing only. For information purposes.